[{"id":"fe93d2c0-1539-4cb3-8ab3-24e78f4e9e29","acronym":"","url":"https://clinicaltrials.gov/study/NCT03984383","created_at":"2021-01-18T19:35:45.975Z","updated_at":"2024-07-02T16:36:01.021Z","phase":"","brief_title":"IL-33, Endocan and Endothelial Cells","source_id_and_acronym":"NCT03984383","lead_sponsor":"University Hospital, Lille","biomarkers":" GAPDH • IL33","pipe":"","alterations":" ","tags":["GAPDH • IL33"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 11/08/2021","start_date":" 11/08/2021","primary_txt":" Primary completion: 11/08/2021","primary_completion_date":" 11/08/2021","study_txt":" Completion: 11/08/2021","study_completion_date":" 11/08/2021","last_update_posted":"2022-11-04"},{"id":"b0eb940c-240b-420a-b995-ea0878dc07ac","acronym":"","url":"https://clinicaltrials.gov/study/NCT04540224","created_at":"2021-01-18T21:43:28.301Z","updated_at":"2024-07-02T16:36:05.814Z","phase":"","brief_title":"The Relationship Between the Differences in Blood Cytokine Values in Breast Cancers.","source_id_and_acronym":"NCT04540224","lead_sponsor":"Istanbul Training and Research Hospital","biomarkers":" IL6 • CXCL8 • IL10 • IL18 • IL17A • IL23A • IL33","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL10 • IL18 • IL17A • IL23A • IL33"],"overall_status":"Completed","enrollment":" Enrollment 78","initiation":"Initiation: 08/01/2020","start_date":" 08/01/2020","primary_txt":" Primary completion: 12/01/2021","primary_completion_date":" 12/01/2021","study_txt":" Completion: 05/01/2022","study_completion_date":" 05/01/2022","last_update_posted":"2022-08-09"},{"id":"25fe0366-9fcc-46e6-9e6e-7ecaf7006bd4","acronym":"","url":"https://clinicaltrials.gov/study/NCT03683147","created_at":"2022-07-25T23:00:13.654Z","updated_at":"2024-07-02T16:36:06.832Z","phase":"","brief_title":"Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer","source_id_and_acronym":"NCT03683147","lead_sponsor":"Roswell Park Cancer Institute","biomarkers":" IL6 • TNFA • IL2 • CCL20 • IL10 • IL17A • IL23A • IL1RN • IL21 • IL22 • IFNL2 • IL33","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL2 • CCL20 • IL10 • IL17A • IL23A • IL1RN • IL21 • IL22 • IFNL2 • IL33"],"overall_status":"Completed","enrollment":" Enrollment 44","initiation":"Initiation: 12/13/2017","start_date":" 12/13/2017","primary_txt":" Primary completion: 06/19/2019","primary_completion_date":" 06/19/2019","study_txt":" Completion: 04/06/2020","study_completion_date":" 04/06/2020","last_update_posted":"2022-07-25"},{"id":"110ea52b-e84e-4c4f-ac59-5c89e4d16963","acronym":"EPITHEM","url":"https://clinicaltrials.gov/study/NCT04576429","created_at":"2021-01-18T21:50:49.552Z","updated_at":"2024-07-02T16:36:16.766Z","phase":"","brief_title":"Immune Profiles Evolution Under Immunotherapy for Melanoma","source_id_and_acronym":"NCT04576429 - EPITHEM","lead_sponsor":"Assistance Publique - Hôpitaux de Paris","biomarkers":" VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33","pipe":"","alterations":" ","tags":["VEGFA • IFNG • IL6 • TNFA • CXCL10 • IL2 • CCL20 • IL10 • CCL19 • CCL2 • GZMB • IL17A • IL1A • IFNA1 • IL1B • IL1RN • TGFA • TNFSF10 • CXCL1 • IL33"],"overall_status":"Recruiting","enrollment":" Enrollment 360","initiation":"Initiation: 01/27/2021","start_date":" 01/27/2021","primary_txt":" Primary completion: 01/01/2031","primary_completion_date":" 01/01/2031","study_txt":" Completion: 01/01/2031","study_completion_date":" 01/01/2031","last_update_posted":"2022-02-23"},{"id":"87192719-3eea-4afc-b9f2-841eee5256c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT04787588","created_at":"2021-04-19T03:52:48.153Z","updated_at":"2024-07-02T16:36:33.698Z","phase":"","brief_title":"COVID-19 Infection and Epithelial Cell Markers","source_id_and_acronym":"NCT04787588","lead_sponsor":"McMaster University","biomarkers":" TSLP • IL33","pipe":"","alterations":" ","tags":["TSLP • IL33"],"overall_status":"Recruiting","enrollment":" Enrollment 235","initiation":"Initiation: 02/14/2021","start_date":" 02/14/2021","primary_txt":" Primary completion: 12/01/2021","primary_completion_date":" 12/01/2021","study_txt":" Completion: 02/01/2022","study_completion_date":" 02/01/2022","last_update_posted":"2021-03-08"},{"id":"54ba2299-c6a8-48de-8382-4bbefedd7248","acronym":"","url":"https://clinicaltrials.gov/study/NCT02916147","created_at":"2021-01-18T14:18:58.739Z","updated_at":"2024-07-02T16:37:28.870Z","phase":"","brief_title":"Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy","source_id_and_acronym":"NCT02916147","lead_sponsor":"Tianjin Medical University Cancer Institute and Hospital","biomarkers":" HMGB1 • HMGN1 • IL33","pipe":"","alterations":" ","tags":["HMGB1 • HMGN1 • IL33"],"overall_status":"Unknown status","enrollment":" Enrollment 40","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 11/01/2018","primary_completion_date":" 11/01/2018","study_txt":" Completion: 01/01/2019","study_completion_date":" 01/01/2019","last_update_posted":"2016-09-27"}]